Annual Non Current Assets
$146.51 M
-$1.78 M-1.20%
31 December 2023
Summary:
Pharming Group NV annual long term assets is currently $146.51 million, with the most recent change of -$1.78 million (-1.20%) on 31 December 2023. During the last 3 years, it has fallen by -$8.73 million (-5.62%). PHAR annual non current assets is now -5.62% below its all-time high of $155.24 million, reached on 31 December 2020.PHAR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$143.32 M
-$1.97 M-1.36%
30 September 2024
Summary:
Pharming Group NV quarterly long term assets is currently $143.32 million, with the most recent change of -$1.97 million (-1.36%) on 30 September 2024. Over the past year, it has dropped by -$1.41 million (-0.97%). PHAR quarterly non current assets is now -10.85% below its all-time high of $160.76 million, reached on 30 June 2021.PHAR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | -1.0% |
| 3 y3 years | -5.6% | -9.7% |
| 5 y5 years | +29.3% | +10.1% |
PHAR Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.6% | at low | -9.7% | +10.0% |
| 5 y | 5 years | -5.6% | +29.3% | -10.8% | +10.1% |
| alltime | all time | -5.6% | +1935.1% | -10.8% | +1983.2% |
Pharming Group NV Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $143.32 M(-1.4%) |
| June 2024 | - | $145.30 M(+0.1%) |
| Mar 2024 | - | $145.12 M(-1.0%) |
| Dec 2023 | $316.34 M(+14.0%) | $146.51 M(+1.2%) |
| Sept 2023 | - | $144.73 M(-4.3%) |
| June 2023 | - | $151.23 M(-3.6%) |
| Mar 2023 | - | $156.94 M(+5.8%) |
| Dec 2022 | $277.50 M(+11.2%) | $148.30 M(+13.8%) |
| Sept 2022 | - | $130.28 M(-4.9%) |
| June 2022 | - | $136.92 M(-3.5%) |
| Mar 2022 | - | $141.85 M(-4.1%) |
| Dec 2021 | $249.44 M(-5.2%) | $147.87 M(-6.8%) |
| Sept 2021 | - | $158.71 M(-1.3%) |
| June 2021 | - | $160.76 M(+9.6%) |
| Mar 2021 | - | $146.74 M(-5.5%) |
| Dec 2020 | $263.21 M(+120.4%) | $155.24 M(+8.6%) |
| Sept 2020 | - | $142.91 M(+4.4%) |
| June 2020 | - | $136.90 M(-0.7%) |
| Mar 2020 | - | $137.89 M(+1.0%) |
| Dec 2019 | $119.44 M(-9.6%) | $136.48 M(+4.8%) |
| Sept 2019 | - | $130.23 M(+9.5%) |
| June 2019 | - | $118.91 M(+8.2%) |
| Mar 2019 | - | $109.91 M(-3.0%) |
| Dec 2018 | $132.05 M(+24.7%) | $113.29 M(+26.3%) |
| Sept 2018 | - | $89.67 M(+2.2%) |
| June 2018 | - | $87.75 M(-6.7%) |
| Mar 2018 | - | $94.00 M(+0.5%) |
| Dec 2017 | $105.87 M(+61.9%) | $93.50 M(+20.1%) |
| Sept 2017 | - | $77.84 M(+3.3%) |
| June 2017 | - | $75.33 M(+7.9%) |
| Mar 2017 | - | $69.82 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $65.41 M(+17.1%) | $67.93 M(+672.2%) |
| Sept 2016 | - | $8.80 M(+7.7%) |
| June 2016 | - | $8.17 M(+10.2%) |
| Mar 2016 | - | $7.41 M(+3.0%) |
| Dec 2015 | $55.86 M(-6.5%) | $7.20 M(-1.5%) |
| Sept 2015 | - | $7.31 M(-0.8%) |
| June 2015 | - | $7.37 M(+7.1%) |
| Mar 2015 | - | $6.88 M(-14.0%) |
| Dec 2014 | $59.76 M(+75.9%) | $8.00 M(+0.4%) |
| Sept 2014 | - | $7.96 M(-10.3%) |
| June 2014 | - | $8.87 M(-1.3%) |
| Mar 2014 | - | $8.99 M(-4.4%) |
| Dec 2013 | $33.97 M(+204.0%) | $9.40 M(-3.4%) |
| Sept 2013 | - | $9.73 M(-4.2%) |
| June 2013 | - | $10.16 M(+4.5%) |
| Mar 2013 | - | $9.73 M(-12.4%) |
| Dec 2012 | $11.17 M(-34.5%) | $11.10 M(-3.0%) |
| Sept 2012 | - | $11.44 M(-23.1%) |
| Mar 2012 | - | $14.89 M(-0.4%) |
| Dec 2011 | $17.06 M(-56.1%) | $14.95 M(-1.9%) |
| Sept 2011 | - | $15.23 M(-6.8%) |
| June 2011 | - | $16.34 M(+30.0%) |
| Mar 2011 | - | $12.57 M(+17.6%) |
| Dec 2010 | $38.90 M(-5.0%) | $10.69 M(-68.6%) |
| Sept 2010 | - | $34.02 M(+2.7%) |
| June 2010 | - | $33.12 M(-10.1%) |
| Mar 2010 | - | $36.84 M(-5.8%) |
| Dec 2009 | $40.93 M(-40.7%) | $39.13 M |
| Dec 2008 | $69.07 M(-39.8%) | - |
| Dec 2007 | $114.75 M(+105.0%) | - |
| Dec 2006 | $55.97 M(+85.2%) | - |
| Dec 2005 | $30.22 M | - |
FAQ
- What is Pharming Group NV annual long term assets?
- What is the all time high annual non current assets for Pharming Group NV?
- What is Pharming Group NV annual non current assets year-on-year change?
- What is Pharming Group NV quarterly long term assets?
- What is the all time high quarterly non current assets for Pharming Group NV?
- What is Pharming Group NV quarterly non current assets year-on-year change?
What is Pharming Group NV annual long term assets?
The current annual non current assets of PHAR is $146.51 M
What is the all time high annual non current assets for Pharming Group NV?
Pharming Group NV all-time high annual long term assets is $155.24 M
What is Pharming Group NV annual non current assets year-on-year change?
Over the past year, PHAR annual long term assets has changed by -$1.78 M (-1.20%)
What is Pharming Group NV quarterly long term assets?
The current quarterly non current assets of PHAR is $143.32 M
What is the all time high quarterly non current assets for Pharming Group NV?
Pharming Group NV all-time high quarterly long term assets is $160.76 M
What is Pharming Group NV quarterly non current assets year-on-year change?
Over the past year, PHAR quarterly long term assets has changed by -$1.41 M (-0.97%)